U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pedi

U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030

The U.S. clinical nutrition market share is anticipated to increase commendably over 2022-2030, on account of the steady rise in the number of geriatric people susceptible to chronic diseases.

Based on data from the U.S. Department of Health and Human Services, over 10,000 people turn 65 years of age every day in the country. Since aging can increase the risk of heart disease, cancer, diabetes, and other chronic conditions, the clinical nutrition health center network is slated to expand significantly across the nation.

With the rising elderly population, the regional medical sector is also focused on home healthcare to cut costs and improve patient experiences. Care delivery at home settings can ensure convenient access, better palliative care, enhanced quality of life, and detection of social health determinants. These benefits are likely to boost the reliance on clinical nutritionists for disease management in home-healthcare settings.

The U.S. clinical nutrition industry is divided based on product, consumer, application, and distribution channel.

U.S. clinical nutrition market share from the parenteral nutrition product segment is expected to increase considerably over the forecast period, given the mounting cases of preterm birth in the United States. According to statistics from the March of Dimes organization, in 2020, 364,487 premature birth cases were registered in the U.S., representing 10.1% of all live births.

Since parenteral nutrition is being adopted as an effective therapeutic option to maintain the nutrition status, achieve balanced somatic, and mimic intrauterine growth in premature infants, the adoption of clinical nutrition is expected to increase significantly across the U.S.

In terms of the consumer, the adult segment is slated to account for a major share of the U.S. clinical nutrition market by 2030, as a result of the growing burden of liver diseases. As per the American Liver Foundation, over 100 million people are diagnosed with some form of liver disease in the country, of which 4.5 million are adults.

Muscle wasting and weight loss are common symptoms found in these patients. Since there is an association between poor clinical outcomes and malnutrition, liver patients are often treated with enteral nutrition, parenteral nutrition, and oral nutritional supplements. With the high incidence of liver disease, the adoption of nutrition therapy will rise and consequently augment the clinical supplement demand.

U.S. clinical nutrition industry value from the neurological diseases application segment is set to rise over 2022-2030, considering the growing prevalence of progressive age-related brain disorders.

Based on the data from Alzheimer’s Association, over 6 million people in America are living with Alzheimer’s disease, with people aged 65 years and above accounting for over 10% of patients. Since proper nutrition can help ease disease symptoms, clinical nutrition is likely to emerge as a prominent solution for the treatment of neurological conditions across the U.S.

In terms of the distribution channel, the market size from the online channels segment is anticipated to depict a high growth rate over the estimated timeline, due to the expansion of digital health services.

In March 2021, New York-based digital health company Ro secured USD 500 million to scale up its online pharmacy services and other digital platforms. Initiatives such as these are expected to influence clinical nutrition industry trends in the U.S.